FDA Approves Gene Therapy Drug That Costs $2.1 Million

Geo Beats 2019-05-25

Views 25

A new gene therapy drugs costs $2.1 million.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA Approves Drug That Costs a Whopping $700,000 a Year
play
00:52

FDA Approves Drug That Costs a Whopping $700,000 a Year
FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in the US
play
00:40

FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in the US
FDA approves first-ever generic version of insulin, which will dramatically cut costs
play
01:32

FDA approves first-ever generic version of insulin, which will dramatically cut costs
FDA Approves Gene Therapy for Inherited Blindness
play
00:43

FDA Approves Gene Therapy for Inherited Blindness
FDA Approves DNA Ancestry Kit to Test for Breast Cancer Gene Mutations
play
01:23

FDA Approves DNA Ancestry Kit to Test for Breast Cancer Gene Mutations
Breakthrough or risk FDA approves Alzheimer's drug
play
01:33

Breakthrough or risk FDA approves Alzheimer's drug
FDA Approves Asthma Drug to Mitigate Fatal Food Allergy Reactions
play
01:10

FDA Approves Asthma Drug to Mitigate Fatal Food Allergy Reactions
FDA approves first postpartum depression drug, Zurzuvae - 1breakingnews.com
play
00:23

FDA approves first postpartum depression drug, Zurzuvae - 1breakingnews.com
FDA approves new Alzheimer’s drug from Eli Lilly
play
01:30

FDA approves new Alzheimer’s drug from Eli Lilly
FDA approves drug to delay onset of Type 1 diabetes - 1breakingnews.com
play
02:04

FDA approves drug to delay onset of Type 1 diabetes - 1breakingnews.com
FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
play
00:23

FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
FDA approves first COVID-19 drug: antiviral remdesivir, and other top stories in business from October 23, 2020.
play
00:51

FDA approves first COVID-19 drug: antiviral remdesivir, and other top stories in business from October 23, 2020.